MediPharm Labs Corp. (LABS.TO)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.08 Million CAD | 56.37% |
| 2022 | -29.98 Million CAD | 45.29% |
| 2021 | -54.8 Million CAD | 18.34% |
| 2020 | -67.11 Million CAD | -6033.69% |
| 2019 | 1.13 Million CAD | 113.45% |
| 2018 | -8.41 Million CAD | -749.6% |
| 2017 | -990 Thousand CAD | -639.16% |
| 2016 | -133.93 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.58 Million CAD | 28.47% |
| 2024 Q1 | -3.61 Million CAD | -21.79% |
| 2023 FY | -13.08 Million CAD | 56.37% |
| 2023 Q4 | -2.96 Million CAD | 31.48% |
| 2023 Q3 | -4.32 Million CAD | -60.08% |
| 2023 Q2 | -2.7 Million CAD | 12.47% |
| 2023 Q1 | -3.08 Million CAD | 44.95% |
| 2022 Q1 | -7.45 Million CAD | 65.74% |
| 2022 FY | -29.98 Million CAD | 45.29% |
| 2022 Q4 | -5.6 Million CAD | 28.22% |
| 2022 Q3 | -7.81 Million CAD | 13.04% |
| 2022 Q2 | -8.98 Million CAD | -20.52% |
| 2021 FY | -54.8 Million CAD | 18.34% |
| 2021 Q4 | -21.76 Million CAD | -195.89% |
| 2021 Q3 | -7.35 Million CAD | 37.72% |
| 2021 Q2 | -11.81 Million CAD | 14.82% |
| 2021 Q1 | -13.86 Million CAD | 55.2% |
| 2020 Q3 | -14.96 Million CAD | -346.09% |
| 2020 Q2 | -3.35 Million CAD | 80.37% |
| 2020 Q1 | -17.08 Million CAD | -430.68% |
| 2020 FY | -67.11 Million CAD | -6033.69% |
| 2020 Q4 | -30.95 Million CAD | -106.86% |
| 2019 FY | 1.13 Million CAD | 113.45% |
| 2019 Q3 | 3.37 Million CAD | 68.88% |
| 2019 Q2 | 1.99 Million CAD | 491.96% |
| 2019 Q1 | -510 Thousand CAD | 85.47% |
| 2019 Q4 | -3.22 Million CAD | -195.38% |
| 2018 Q4 | -3.51 Million CAD | -3297.23% |
| 2018 Q2 | -10.95 Thousand CAD | 94.74% |
| 2018 Q1 | -208.27 Thousand CAD | -849.45% |
| 2018 FY | -8.41 Million CAD | -749.6% |
| 2018 Q3 | -103.34 Thousand CAD | -843.14% |
| 2017 FY | -990 Thousand CAD | -639.16% |
| 2017 Q3 | -39.78 Thousand CAD | -29.34% |
| 2017 Q2 | -30.76 Thousand CAD | 71.12% |
| 2017 Q1 | -106.52 Thousand CAD | 0.0% |
| 2017 Q4 | -21.93 Thousand CAD | 44.86% |
| 2016 FY | -133.93 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | 81.128% |
| Avicanna Inc. | -8.74 Million CAD | -49.64% |
| Avant Brands Inc. | -5.07 Million CAD | -158.047% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | 53.488% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -558.761% |
| Knight Therapeutics Inc. | -16.83 Million CAD | 22.287% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 94.299% |
| Canopy Growth Corporation | -657.26 Million CAD | 98.009% |
| Willow Biosciences Inc. | -13.02 Million CAD | -0.414% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | 70.607% |